Infective endocarditis following tumor necrosis factor-α antagonist therapy for management of psoriatic erythroderma: a case report

The introduction of biological agents, such as infliximab, which act against tumor necrosis factor-α was a major advance for the treatment of an increasing number of chronic diseases. Tumor necrosis factor-α antagonists represent a major therapeutic advance for the management of chronic inflammatory...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical case reports 2017-02, Vol.11 (1), p.35-35, Article 35
Hauptverfasser:	Mizuno, Takuro, Kiyosawa, Jun, Fukuda, Akihiro, Watanabe, Seiji, Kurose, Nozomu, Nojima, Takayuki, Kanda, Tsugiyasu
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Bacterial infections Blood Brain Infarction - microbiology Brain Infarction - pathology Cardiovascular disease Case Report Consent Dermatitis, Exfoliative - complications Dermatitis, Exfoliative - drug therapy Dermatologic Agents - administration & dosage Dermatologic Agents - adverse effects Embolisms Endocarditis - complications Endocarditis - drug therapy Family medical history Fatal Outcome Gangrene Humans Infections Infliximab - administration & dosage Infliximab - adverse effects Male Mortality NMR Nuclear magnetic resonance Patients Prednisolone - administration & dosage Prednisolone - adverse effects Psoriasis Rheumatoid arthritis Substance abuse treatment Tomography Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor necrosis factor-TNF Ultrasonic imaging Vegetation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!